Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/104626
DC FieldValueLanguage
dc.contributor.authorCardoso, João-
dc.contributor.authorFerreira, António Jorge-
dc.contributor.authorGuimarães, Miguel-
dc.contributor.authorOliveira, Ana Sofia-
dc.contributor.authorSimão, Paula-
dc.contributor.authorSucena, Maria-
dc.date.accessioned2023-01-20T12:36:29Z-
dc.date.available2023-01-20T12:36:29Z-
dc.date.issued2021-
dc.identifier.issn1178-2005pt
dc.identifier.urihttps://hdl.handle.net/10316/104626-
dc.description.abstractThe well-recognized individual heterogeneity within COPD patients has led to a growing interest in greater personalization in the approach of these patients. Thus, the treatable traits strategy has been proposed as a further step towards precision medicine in the management of chronic airway disease, both in stable phase and acute exacerbations. The aim of this paper is to perform a critical review on the treatable traits strategy and propose a guide to approach COPD patients in the light of this new concept. An innovative stepwise approach is proposed - a multidisciplinary model based on two distinct phases, with the potential to be implemented in both primary care and hospital settings. The first phase is the initial and focused assessment of a selected subset of treatable traits, which should be addressed in all COPD patients in both settings (primary care and hospital). As some patients may present with advanced disease at diagnosis or may progress despite this initial treatment requiring a more specialized assessment, they should progress to a second phase, in which a broader approach is recommended. Beyond stable COPD, we explore how the treatable traits strategy may be applied to reduce the risk of future exacerbations and improve the management of COPD exacerbations. Since many treatable traits have already been related to exacerbation risk, the strategy proposed here represents an opportunity to be proactive. Although it still lacks prospective validation, we believe this is the way forward for the future of the COPD approach.pt
dc.language.isoengpt
dc.publisherDove Medical Presspt
dc.relationBialpt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt
dc.subjectCOPDpt
dc.subjectprecision medicinept
dc.subjecttreatable traits strategypt
dc.subjectphased approachpt
dc.subjectfuturept
dc.subject.meshHumanspt
dc.subject.meshPhenotypept
dc.subject.meshPrecision Medicinept
dc.subject.meshAsthmapt
dc.subject.meshPulmonary Disease, Chronic Obstructivept
dc.titleTreatable Traits in COPD - A Proposed Approachpt
dc.typearticle-
degois.publication.firstPage3167pt
degois.publication.lastPage3182pt
degois.publication.titleInternational Journal of COPDpt
dc.peerreviewedyespt
dc.identifier.doi10.2147/COPD.S330817pt
degois.publication.volume16pt
dc.date.embargo2021-01-01*
uc.date.periodoEmbargo0pt
item.cerifentitytypePublications-
item.languageiso639-1en-
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypearticle-
crisitem.author.orcid0000-0002-1016-977X-
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais
Files in This Item:
Show simple item record

SCOPUSTM   
Citations

19
checked on May 6, 2024

WEB OF SCIENCETM
Citations

17
checked on May 2, 2024

Page view(s)

49
checked on May 21, 2024

Download(s)

40
checked on May 21, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons